Clinical study on efficacy of Aidi injection combined with PT chemotherapy protocol in advanced esophageal cancer patients / 肿瘤研究与临床

ABSTRACT

Objective To compare and analyze the effect of single PT (taxol,cisplatin) chemotherapy and the PT chemotherapy combined with Aidi injection in the medium and advanced esophageal patients,in order to maximize the strength chemotherapy' s effects,reduce the side effects,improve the patients' life qualities.Methods 106 cases of esophageal patients were randomly divided into two groups,53 patients for each group.The control group were treated by the single PT chemotherapy protocol,while the treatment group were combined with Aidi and PT chemotherapy protocol,21 days time peroid was taken as one circle.After two weeks,the effect,the patients' life qualities and the side effects between two groups were compared.Results The effective rates of treatment group and control group were 90.37 ％ (48/53) and 81.13 ％ (43/53),respectively,there was no statistic significance (P ＞ 0.05).The median-survival in two groups were 48 weeks and 42 weeks,which was statistic significance (P =0.027).The treatment group' s side effects incidence rate was lower than that of control group in Ⅲ-Ⅳ degree gastrointestinal reaction (Ⅲ degree P =0.026,Ⅳ degree P =0.027),Ⅲ-Ⅳ degree of inhibition of white blood cells (Ⅲ degree P =0.038,Ⅳ degree P =0.040),Ⅲ degree platelet inhibition (P =0.023) and Ⅱ-Ⅲ degree hypohemia (Ⅱ degree P =0.020,Ⅲ degree P =0.041).There were no statistically differences between treatment group and control group in liver,muscle,kidney toxicity and baldness (P ＞ 0.05).There were significant differences in Karnofsky score and body mass between pre-and post-treatment in chemotherapy group (P =0.067),but those in treatment group were not (P =0.006).Conclusion The Aidi injection combined with PT chemotherapy protocol has a better effect in the esophageal cancer patients,longer median survival time,reduced the side effects and improved the patients' life qualities,which is deserved to be used in the clinical furtherly.